top of page


Press releases


Nov 4, 2024
Sachi's Nanoligomer treatments and nearly 600 patient-based brain Organoids fly on NASA's Space X CRS 31 Mission
Sachi Bio plans to utilize brain organoids in microgravity, which is the state of apparent weightlessness experienced during free fall or...

Nov 10, 2023
Sachi Bio's Research into Exploring Brain Aging in Space flies on SpaceX CRS-29
Sachi Bio is sending samples to International Space Station (ISS) Labs to study the effect of microgravity on brain aging and disease...


Aug 31, 2023
Sachi Bio presents at ISSR&D Conference as it aims to become the first company in the world to test RNA Therapeutics in Space
Sachi Bio presented data on human brain organoids and their treatment with Nanoligomers, to the space community in the ISSR&D conference...


Aug 2, 2022
Sachi Bio selected in the NASA I-Corps Program
Sachi Bio has been selected in the 2022 cohort of the NASA I-Corps program. The NASA I-Corps program enables small businesses, including...


May 1, 2022
Sachi Bio wins NASA SBIR Phase II award
Reversing Immune Dysregulation During Spaceflight Missions May 1st, 2022 We are pleased to announce that Sachi Bioworks has won Phase II...


Mar 25, 2021
Sachi Bio wins Phase I NASA SBIR grant
March 25th, 2021 Sachi Bio will be working with NASA to develop novel therapeutics for radiation countermeasures for deployment in space...


Subscribe to Our Newsletter
bottom of page